These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proteomics of severe SARS-COV-2 infection and paraquat poisoning in human lung tissue samples: comparison of microbial infected and toxic pulmonary fibrosis. Min J; Jiaqi H; Lihua L; Qianqian C; Shujuan W; Xiang L; Liang L; Liang R; Yiwu Z; Qian L Front Cell Infect Microbiol; 2024; 14():1446305. PubMed ID: 39301288 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients. Giacomelli C; Piccarducci R; Marchetti L; Romei C; Martini C Biochem Pharmacol; 2021 Nov; 193():114812. PubMed ID: 34687672 [TBL] [Abstract][Full Text] [Related]
5. [Pulmonary fibrosis in patients with COVID-19: A review]. Chuchalin AG Ter Arkh; 2022 Dec; 94(11):1333-1339. PubMed ID: 37167174 [TBL] [Abstract][Full Text] [Related]
13. Effect of apigetrin in pseudo-SARS-CoV-2-induced inflammatory and pulmonary fibrosis in vitro model. Han H; Kim JE; Lee HJ Sci Rep; 2024 Jun; 14(1):14545. PubMed ID: 38914619 [TBL] [Abstract][Full Text] [Related]
14. COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis. Vaz de Paula CB; Nagashima S; Liberalesso V; Collete M; da Silva FPG; Oricil AGG; Barbosa GS; da Silva GVC; Wiedmer DB; da Silva Dezidério F; Noronha L Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008594 [TBL] [Abstract][Full Text] [Related]